The National Agency for Food and Drug Administration and Control (NAFDAC) says it has approved two herbal drugs to undergo clinical trials for the treatment of COVID-19.
A statement on Sunday by the agency resident media consultant, Olusayo Akintola, however, denounced the claim of approval of IH
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
